Marín-Rincón Hamilton Andrés, Machado-Duque Manuel E, Machado-Alba Jorge E
Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A., Pereira, Risaralda, Colombia.
Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A., Pereira, Risaralda, Colombia; Grupo Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
Rev Colomb Psiquiatr (Engl Ed). 2020 Dec 29. doi: 10.1016/j.rcp.2020.11.004.
Antidepressants are useful in the pharmacological treatment of different depressive and anxiety disorders, as well as being potentially useful in other indications. The aim of the study was to determine the indications for which antidepressants are being prescribed in patients over 18 years of age registered with the Colombian Health System.
Retrospective study with data from patients over 18 years old, of either sex, registered with the Colombian Health System, who are prescribed antidepressants. Medical records were reviewed, looking for indications approved and not approved by regulatory agencies. Patients were identified randomly, as well as the sociodemographic, clinical and pharmacological variables that could be associated with prescriptions for unapproved indications.
351 patients were evaluated, with a mean age of 60.4±15.3 years, of whom 72.6% were women. They were attended in 34 cities, with prescriptions mainly by general practitioners (n=276; 78.6%), and psychiatrists (n=42; 12.0%). Selective serotonin reuptake inhibitors were the most widely prescribed antidepressants (n=204; 58.1%), followed by atypicals (n=76; 21.7%). The most frequent indications were for depression (n=169; 48.1%), anxiety (n=48; 13.7%), pain (n=22; 6.3%) and sleep disorders (n=17; 4.8%). A total of 188 prescriptions (53.6%) were made for approved indications, and the remaining 163 (46.4%) were classified as unapproved.
Antidepressants are being prescribed for the treatment of depression, anxiety, pain and sleep disorders, especially in older adult women, but almost half of the formulations were for unapproved indications.
抗抑郁药在不同抑郁和焦虑症的药物治疗中很有用,在其他适应症中也可能有用。本研究的目的是确定哥伦比亚卫生系统登记的18岁以上患者中开具抗抑郁药的适应症。
对哥伦比亚卫生系统登记的18岁以上、无论性别、开具抗抑郁药的患者数据进行回顾性研究。查阅病历,寻找监管机构批准和未批准的适应症。随机确定患者,以及可能与未批准适应症处方相关的社会人口统计学、临床和药理学变量。
共评估了351例患者,平均年龄为60.4±15.3岁,其中72.6%为女性。他们来自34个城市,主要由全科医生(n=276;78.6%)和精神科医生(n=42;12.0%)开具处方。选择性5-羟色胺再摄取抑制剂是处方最广泛的抗抑郁药(n=204;58.1%),其次是非典型抗抑郁药(n=76;21.7%)。最常见的适应症是抑郁症(n=169;48.1%)、焦虑症(n=48;13.7%)、疼痛(n=22;6.3%)和睡眠障碍(n=17;4.8%)。共有188张处方(53.6%)用于批准的适应症,其余163张(46.4%)被归类为未批准。
抗抑郁药被用于治疗抑郁症、焦虑症、疼痛和睡眠障碍,尤其是老年女性,但几乎一半的处方是用于未批准的适应症。